Cite
APA Citation
Farrell, S., Karp, J., Hager, R., Wang, Y., Adeniyi, O., Wang, J., Li, L., Ma, L., Peretz, J., Summan, M., Kong, N., White, M., Pacanowski, M., Price, D., Filie, J., Donohue, K., & Joffe, H. (2021). regulatory news: Nulibry (fosdenopterin) approved to reduce the risk of mortality in patients with molybdenum cofactor deficiency type A: FDA approval summary. Journal of inherited metabolic disease, 44(5), 1085–1087. http://access.bl.uk/ark:/81055/vdc_100142195068.0x00004f